Tempus AI Inc. TEM shares are up on Thursday as Mizuho initiated coverage on the health care-focused artificial intelligence firm. Analyst Bradley Bowers started coverage with an Outperform rating and ...
Animalogic on MSN
This is the most deadly mushroom growing in your backyard
Several highly toxic mushroom species commonly grow in residential lawns and wooded backyards, often resembling edible ...
This prompts a reassessment of the stock’s value to determine if this represents a genuine opportunity or a potential trap.
Researchers identified how the poxvirus protein VITF-3 forms a molecular ring that clamps onto DNA with viral RNA polymerase, ...
Reducing Uncertainty in the Care and Treatment of Blood Cancer ST. LOUIS, MO, UNITED STATES, February 23, 2026 ...
Advancements in peptide and oligonucleotide synthesis via precision chemistry are transforming therapeutic development by ...
Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...
Detailed price information for Inhibikase Therapeutics Inc (IKT-Q) from The Globe and Mail including charting and trades.
Learn more about whether Apellis Pharmaceuticals, Inc. or Kymera Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether Alkermes plc or Apellis Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Therapeutic vaccines are advancing in oncology and HIV, with the aim of retraining immune responses to target tumors and persistent viral reservoirs with precision.
Alkermes plc announced today that management will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026 at 9:10 a.m. ET (2:10 p.m. GMT). The live ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results